Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Oguogho

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|June 1, 1996
Depressed endothelium-dependent relaxation responses to acetylcholine and histamine in isolated human epigastric arteries from pre-eclamptic womenA Oguogho, C P Aloamaka, A B Ebeigbe
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 4, 2001
6-oxo-PGF(1 alpha)and 8-epi-PGF(2 alpha)in the arterial wall layers of various species: a comparison between intact and atherosclerotic areasA Oguogho, H Kritz, O Wagner, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|December 1, 1995
The effect of NO/EDRF and monocytes/macrophages on LDL-oxidationN Leitinger, A Oguogho, M Rodrigues, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|July 20, 2000
Isoprostanes quickly normalize after quitting cigarette smoking in healthy adultsA Oguogho, G Lupattelli, B Palumbo, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|October 19, 2000
Prostaglandin E1-therapy reduces circulating adhesion molecules (ICAM-1, E-selectin, VCAM-1) in peripheral vascular diseaseB Palumbo, A Oguogho, P Fitscha, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 3, 1999
Semotiadil, a new calcium antagonist, is a very potent inhibitor of LDL-oxidationH Kritz, A Oguogho, A A Aghajanian, et al.
Angiology|June 6, 2003
8-Epi-PGF2alpha and 6-oxo-PGF1alpha in human (varicose) veins: influence of age, sex, and risk factorsSusan Meghdadi, Margarida Rodrigues, A Oguogho, et al.
Prostaglandins & Other Lipid Mediators|July 13, 1999
Maternal cigarette smoking increases F2-isoprostanes and reduces prostacyclin and nitric oxide in umbilical vesselsR Obwegeser, A Oguogho, M Ulm, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 1, 1997
Chloroquine minimizes sampling artefacts for radioimmunological determination of thromboxane B2 in plasmaA Oguogho, B al-Malicky, H Kritz, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 26, 2002
Effect of giving up cigarette smoking and restarting in patients with clinically manifested atherosclerosisF Chehne, A Oguogho, G Lupattelli, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|June 1, 1996
Depressed endothelium-dependent relaxation responses to acetylcholine and histamine in isolated human epigastric arteries from pre-eclamptic womenA Oguogho, C P Aloamaka, A B Ebeigbe
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 4, 2001
6-oxo-PGF(1 alpha)and 8-epi-PGF(2 alpha)in the arterial wall layers of various species: a comparison between intact and atherosclerotic areasA Oguogho, H Kritz, O Wagner, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|December 1, 1995
The effect of NO/EDRF and monocytes/macrophages on LDL-oxidationN Leitinger, A Oguogho, M Rodrigues, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|July 20, 2000
Isoprostanes quickly normalize after quitting cigarette smoking in healthy adultsA Oguogho, G Lupattelli, B Palumbo, et al.
VASA. Zeitschrift Fur Gefasskrankheiten|October 19, 2000
Prostaglandin E1-therapy reduces circulating adhesion molecules (ICAM-1, E-selectin, VCAM-1) in peripheral vascular diseaseB Palumbo, A Oguogho, P Fitscha, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|December 3, 1999
Semotiadil, a new calcium antagonist, is a very potent inhibitor of LDL-oxidationH Kritz, A Oguogho, A A Aghajanian, et al.
Angiology|June 6, 2003
8-Epi-PGF2alpha and 6-oxo-PGF1alpha in human (varicose) veins: influence of age, sex, and risk factorsSusan Meghdadi, Margarida Rodrigues, A Oguogho, et al.
Prostaglandins & Other Lipid Mediators|July 13, 1999
Maternal cigarette smoking increases F2-isoprostanes and reduces prostacyclin and nitric oxide in umbilical vesselsR Obwegeser, A Oguogho, M Ulm, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|May 1, 1997
Chloroquine minimizes sampling artefacts for radioimmunological determination of thromboxane B2 in plasmaA Oguogho, B al-Malicky, H Kritz, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|November 26, 2002
Effect of giving up cigarette smoking and restarting in patients with clinically manifested atherosclerosisF Chehne, A Oguogho, G Lupattelli, et al.
Pageof 3